What is the latest RATNAMANI stock price?
The latest stored price for RATNAMANI is Rs 2,552.50 as of 2026-07-20.
gimli
RATNAMANI stock AI analysis
RATNAMANI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
RATNAMANI MET & TUB LTD. is a small-cap stock in Capital Goods. This Gimli page shows the latest available RATNAMANI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹2,552.50
1W return
-3.93%
1M return
-7.88%
3M return
+5.16%
6M return
+24.37%
1Y return
-9.19%
Market cap
₹17,890.98 cr
PE
37.08
PB
4.25
ROE
+12.26%
ROCE
+17.67%
RSI
45.28
Turnover
₹5.72 cr
Why it can matter in screens
- Momentum: RATNAMANI is below 50DMA, above 200DMA; RSI is 45.28.
- Returns: 1D -1.17%, 1W -3.93%, 1M -7.88%, 3M +5.16%, 1Y -9.19%.
- Trend levels: 52W high ₹3,046.20, 52W low ₹1,946.40, off high -16.21%.
- Liquidity: latest turnover is ₹5.72 cr; volume vs 20D is +0.63%.
- Valuation/profitability: PE 37.08, PB 4.25, ROE +12.26%, ROCE +17.67%.
- Growth: 3Y sales CAGR +0.24%, 3Y profit CAGR -1.86%.
Quick Answers
Is RATNAMANI above its 50DMA and 200DMA?
RATNAMANI is below 50DMA, above 200DMA. The latest 50DMA is 2,620.78 and the latest 200DMA is 2,414.19.
What are RATNAMANI PE, ROE and ROCE?
RATNAMANI has PE 37.08, ROE +12.26%, and ROCE +17.67% in Gimli's latest available snapshot.
How has RATNAMANI performed recently?
RATNAMANI has returned -7.88% over 1 month, +5.16% over 3 months, and -9.19% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 1,084.82 cr | 195.02 cr | 104.65 cr | 14.94 |
| 2025-12-31 | 1,065.83 cr | 217.68 cr | 109.85 cr | 15.67 |
| 2025-09-30 | 1,191.69 cr | 238.15 cr | 136.22 cr | 19.43 |
| 2025-06-30 | 1,151.62 cr | 218.44 cr | 131.82 cr | 18.81 |
| 2025-03-31 | 1,715.15 cr | 311.24 cr | 207.13 cr | 28.99 |
| 2024-12-31 | 1,316.30 cr | 222.53 cr | 131.31 cr | 18.73 |
| 2024-09-30 | 971.33 cr | 173.05 cr | n/a | 14.17 |
| 2024-06-30 | 1,183.70 cr | 176.31 cr | 105.13 cr | 15.11 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 4,493.96 cr | 869.28 cr | 482.55 cr | 68.85 |
| 2025-03-31 | 5,186.47 cr | 883.14 cr | 543.98 cr | 77.27 |
| 2024-03-31 | 5,027.51 cr | 955.89 cr | 622.79 cr | 88.85 |
| 2023-03-31 | 4,461.16 cr | 798.21 cr | 510.48 cr | 72.83 |
| 2022-03-31 | 3,176.32 cr | 528.43 cr | 322.39 cr | 46.00 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 5,387.60 cr | 73.90 cr | 317.63 cr | 4,207.72 cr |
| 2025-03-31 | 4,905.97 cr | 223.70 cr | 157.40 cr | 3,664.63 cr |
| 2024-03-31 | 4,019.83 cr | 202.60 cr | 152.87 cr | 3,216.20 cr |
| 2023-03-31 | 3,780.28 cr | 26.50 cr | 237.00 cr | 2,675.97 cr |
| 2022-03-31 | 2,962.48 cr | 38.64 cr | 157.46 cr | 2,248.32 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 936.01 cr | 450.75 cr | n/a |
| 2025-03-31 | 536.22 cr | 207.14 cr | n/a |
| 2024-03-31 | 511.23 cr | 298.19 cr | n/a |
| 2023-03-31 | 310.47 cr | 168.59 cr | n/a |
| 2022-03-31 | -283.00 cr | -427.47 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +59.77% | +10.72% | +19.13% | +19.10% | +10.37% | +0.00% |
| 2026-03-31 | +59.77% | +10.60% | +19.45% | +19.35% | +10.15% | +0.00% |
| 2025-12-31 | +59.77% | +11.11% | +18.92% | +18.82% | +10.19% | +0.00% |
| 2025-09-30 | +59.77% | +11.15% | +18.79% | +18.68% | +10.27% | +0.00% |
| 2025-06-30 | +59.77% | +11.28% | +19.19% | +19.09% | +9.74% | +0.00% |
| 2025-03-31 | +59.77% | +11.62% | +18.80% | +18.71% | +9.78% | +0.00% |
| 2024-12-31 | +59.77% | +11.55% | +18.74% | +18.63% | +9.92% | +0.00% |
| 2024-09-30 | +59.77% | +12.71% | +16.76% | +16.39% | +10.75% | +0.00% |
| 2024-06-30 | +59.77% | +12.61% | +16.58% | +16.14% | +11.02% | +0.00% |
| 2024-03-31 | +59.77% | +12.87% | +16.13% | +15.75% | +11.22% | +0.00% |
| 2023-12-31 | +59.77% | +12.77% | +16.29% | +15.96% | +11.17% | +0.00% |
| 2023-09-30 | +59.77% | +12.87% | +16.47% | +16.30% | +10.88% | +0.00% |
| 2023-06-30 | +59.77% | +12.79% | +16.45% | +16.30% | +10.99% | +0.00% |
| 2023-03-31 | +60.06% | +12.77% | +16.39% | +16.29% | +10.77% | +0.00% |
| 2022-12-31 | +60.10% | +12.51% | +16.34% | +16.22% | +11.05% | n/a |
| 2022-09-30 | +60.10% | +12.51% | +16.25% | +16.09% | +11.14% | n/a |
| 2022-07-05 | +60.16% | +0.00% | +28.62% | n/a | n/a | +0.00% |
| 2022-06-30 | +60.16% | +0.00% | +28.64% | n/a | n/a | +0.00% |
| 2022-03-31 | +60.16% | +0.00% | +28.39% | n/a | n/a | +0.00% |
| 2021-12-31 | +60.16% | +0.00% | +28.03% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| HAL | HINDUSTAN AERONAUTICS LTD | 300,346.85 cr | 32.948665 | +23.98% | -3.45% |
| BEL | BHARAT ELECTRONICS LTD | 298,348.62 cr | 49.295652 | +27.51% | +3.39% |
| ABB | ABB INDIA LIMITED | 159,291.54 cr | 53.502373 | +39.93% | +33.13% |
| CUMMINSIND | CUMMINS INDIA LTD | 152,626.32 cr | 64.624249 | +29.45% | +55.71% |
| TMCV | TATA MOTORS LIMITED | 150,736.24 cr | 49.780791 | +26.03% | n/a |
| BHEL | BHEL | 145,376.15 cr | 90.845329 | +6.29% | +66.67% |
| POWERINDIA | HITACHI ENERGY INDIA LTD | 144,592.87 cr | 146.372758 | +21.04% | +70.07% |
| CGPOWER | CG POWER AND IND SOL LTD | 143,706.97 cr | 119.358940 | +19.68% | +36.68% |
Try these prompts
- Analyze RATNAMANI MET & TUB. with valuation, momentum and industry peers
- Compare RATNAMANI with other Capital Goods stocks
- Show small-cap stocks in Capital Goods above 50DMA with positive 1M return
- Find Capital Goods stocks with improving momentum and reasonable valuation
Related screen ideas
- View Capital Goods stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare RATNAMANI with other Capital Goods stocks
Data snapshot: 2026-07-20. Not investment advice.